Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function
出版年份 2017 全文链接
标题
Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function
作者
关键词
-
出版物
MedChemComm
Volume 8, Issue 2, Pages 286-294
出版商
Royal Society of Chemistry (RSC)
发表日期
2016-11-18
DOI
10.1039/c6md00500d
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Filtering promiscuous compounds in early drug discovery: is it a good idea?
- (2016) Mario R. Senger et al. DRUG DISCOVERY TODAY
- Redox signaling: An evolution from free radicals to aging
- (2016) Henry Jay Forman FREE RADICAL BIOLOGY AND MEDICINE
- Synthesis and biological evaluation of novel 2-phenylquinazoline-4-amine derivatives: identification of 6-phenyl-8H-benzo[g]quinazolino[4,3-b]quinazolin-8-one as a highly potent inducer of NAD(P)H quinone oxidoreductase 1
- (2016) Mostafa M. Ghorab et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Design, Synthesis, and Initial Evaluation of Affinity-Based Small-Molecule Probes for Fluorescent Visualization and Specific Detection of Keap1
- (2016) Mengchen Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
- (2016) Thomas G. Davies et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening
- (2016) Falco Kilchmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
- (2016) Meng-Chen Lu et al. MEDICINAL RESEARCH REVIEWS
- A systematic molecular dynamics approach to the study of peptide Keap1–Nrf2 protein–protein interaction inhibitors and its application to p62 peptides
- (2016) Meng-Chen Lu et al. Molecular BioSystems
- Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors
- (2016) Meng-Chen Lu et al. ACS Medicinal Chemistry Letters
- p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
- (2016) Tetsuya Saito et al. Nature Communications
- Exercise, Nrf2 and Antioxidant Signaling in Cardiac Aging
- (2016) Madhusudhanan Narasimhan et al. Frontiers in Physiology
- The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic
- (2015) Maria A. O’Connell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
- (2015) Chunquan Sheng et al. CHEMICAL SOCIETY REVIEWS
- Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
- (2015) Atul D. Jain et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular basis of the Keap1–Nrf2 system
- (2015) Takafumi Suzuki et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
- (2015) Delinda A. Johnson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling
- (2015) Angelika F. Winkel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structure–Activity and Structure–Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1–Nrf2 Protein–Protein Interaction Inhibitor
- (2015) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1–Nrf2 Protein–Protein Interaction
- (2015) Hélène C. Bertrand et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitigating risk in academic preclinical drug discovery
- (2015) Jayme L. Dahlin et al. NATURE REVIEWS DRUG DISCOVERY
- The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes
- (2015) Elango Bhakkiyalakshmi et al. PHARMACOLOGICAL RESEARCH
- Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents
- (2015) Dhulfiqar Ali Abed et al. Acta Pharmaceutica Sinica B
- Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
- (2014) Akhileshwar Namani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex
- (2014) Eric Jnoff et al. ChemMedChem
- Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
- (2014) Chunlin Zhuang et al. CURRENT MEDICINAL CHEMISTRY
- Rapid Identification of Keap1–Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
- (2014) Chunlin Zhuang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
- (2014) Zheng-Yu Jiang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug-Like ProteinProtein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology
- (2014) Bruno O. Villoutreix et al. Molecular Informatics
- Chemistry: Chemical con artists foil drug discovery
- (2014) Jonathan Baell et al. NATURE
- Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
- (2013) Douglas Marcotte et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
- (2013) Longqin Hu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- RXR Inhibits the NRF2-ARE Signaling Pathway through a Direct Interaction with the Neh7 Domain of NRF2
- (2013) H. Wang et al. CANCER RESEARCH
- Oxidative stress in carcinogenesis: new synthetic compounds with dual effects upon free radicals and cancer.
- (2013) Betul Tekiner-Gulbas et al. CURRENT MEDICINAL CHEMISTRY
- Keap Calm, and Carry on Covalently
- (2013) Anthony J. Wilson et al. JOURNAL OF MEDICINAL CHEMISTRY
- NRF2-regulation in brain health and disease: Implication of cerebral inflammation
- (2013) Mats Sandberg et al. NEUROPHARMACOLOGY
- Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction with improved binding and cellular activity
- (2013) Rowena Hancock et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Novel protein–protein interaction inhibitor of Nrf2–Keap1 discovered by structure-based virtual screening
- (2013) Hao-Peng Sun et al. MedChemComm
- Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
- (2012) Tiejun Cheng et al. AAPS Journal
- Gene Therapy Targeting Inflammation in Atherosclerosis
- (2012) Tim Van-Assche et al. CURRENT PHARMACEUTICAL DESIGN
- Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
- (2012) Sadagopan Magesh et al. MEDICINAL RESEARCH REVIEWS
- Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
- (2012) S Chowdhry et al. ONCOGENE
- Structural biology and drug discovery for protein–protein interactions
- (2012) Harry Jubb et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- State-of-the-art in ligand-based virtual screening
- (2011) Peter Ripphausen et al. DRUG DISCOVERY TODAY
- Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction
- (2011) Rowena Hancock et al. FREE RADICAL BIOLOGY AND MEDICINE
- Druggability assessment of protein–protein interfaces
- (2011) Jutta Wanner et al. Future Medicinal Chemistry
- Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease
- (2010) Jeffrey R. Koenitzer et al. Annals of the New York Academy of Sciences
- Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
- (2010) John D. Hayes et al. ANTIOXIDANTS & REDOX SIGNALING
- Discovery of the Negative Regulator of Nrf2, Keap1: A Historical Overview
- (2010) Ken Itoh et al. ANTIOXIDANTS & REDOX SIGNALING
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting NRF2 signaling for cancer chemoprevention
- (2009) Mi-Kyoung Kwak et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity
- (2008) T. Yamamoto et al. MOLECULAR AND CELLULAR BIOLOGY
- Molecular mechanisms of Nrf2-mediated antioxidant response
- (2008) Wenge Li et al. MOLECULAR CARCINOGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started